205 related articles for article (PubMed ID: 23875016)
41. Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles.
Tchou J; Kossenkov AV; Chang L; Satija C; Herlyn M; Showe LC; Puré E
BMC Med Genomics; 2012 Sep; 5():39. PubMed ID: 22954256
[TBL] [Abstract][Full Text] [Related]
42. Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Itoh M; Iwamoto T; Matsuoka J; Nogami T; Motoki T; Shien T; Taira N; Niikura N; Hayashi N; Ohtani S; Higaki K; Fujiwara T; Doihara H; Symmans WF; Pusztai L
Breast Cancer Res Treat; 2014 Jan; 143(2):403-9. PubMed ID: 24337596
[TBL] [Abstract][Full Text] [Related]
43. Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium.
Graham K; Ge X; de Las Morenas A; Tripathi A; Rosenberg CL
Clin Cancer Res; 2011 Jan; 17(2):236-46. PubMed ID: 21059815
[TBL] [Abstract][Full Text] [Related]
44. Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samples.
Dvorkin-Gheva A; Hassell JA
PLoS One; 2011; 6(10):e26023. PubMed ID: 22022496
[TBL] [Abstract][Full Text] [Related]
45. A three-gene model to robustly identify breast cancer molecular subtypes.
Haibe-Kains B; Desmedt C; Loi S; Culhane AC; Bontempi G; Quackenbush J; Sotiriou C
J Natl Cancer Inst; 2012 Feb; 104(4):311-25. PubMed ID: 22262870
[TBL] [Abstract][Full Text] [Related]
46. Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer.
Schneider J; Ruschhaupt M; Buness A; Asslaber M; Regitnig P; Zatloukal K; Schippinger W; Ploner F; Poustka A; Sültmann H
Int J Cancer; 2006 Dec; 119(12):2974-9. PubMed ID: 17019712
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
[TBL] [Abstract][Full Text] [Related]
48. CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.
Shehwana H; Keskus AG; Ozdemir SE; Acikgöz AA; Biyik-Sit R; Cagnan I; Gunes D; Jahja E; Cingir-Koker S; Olmezer G; Sucularli C; Konu O
Cell Oncol (Dordr); 2021 Apr; 44(2):453-472. PubMed ID: 33469842
[TBL] [Abstract][Full Text] [Related]
49. Molecular classification of estrogen receptor-positive/luminal breast cancers.
Geyer FC; Rodrigues DN; Weigelt B; Reis-Filho JS
Adv Anat Pathol; 2012 Jan; 19(1):39-53. PubMed ID: 22156833
[TBL] [Abstract][Full Text] [Related]
50. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
[TBL] [Abstract][Full Text] [Related]
51. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
52. Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.
Baumgarten SC; Frasor J
Mol Endocrinol; 2012 Mar; 26(3):360-71. PubMed ID: 22301780
[TBL] [Abstract][Full Text] [Related]
53. LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
Schwarz LJ; Fox EM; Balko JM; Garrett JT; Kuba MG; Estrada MV; González-Angulo AM; Mills GB; Red-Brewer M; Mayer IA; Abramson V; Rizzo M; Kelley MC; Meszoely IM; Arteaga CL
J Clin Invest; 2014 Dec; 124(12):5490-502. PubMed ID: 25401474
[TBL] [Abstract][Full Text] [Related]
54. Role of estrogen receptor in breast cancer cell gene expression.
Zheng Y; Shao X; Huang Y; Shi L; Chen B; Wang X; Yang H; Chen Z; Zhang X
Mol Med Rep; 2016 May; 13(5):4046-50. PubMed ID: 27035558
[TBL] [Abstract][Full Text] [Related]
55. The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.
Wang Z; Dahiya S; Provencher H; Muir B; Carney E; Coser K; Shioda T; Ma XJ; Sgroi DC
Clin Cancer Res; 2007 Nov; 13(21):6327-34. PubMed ID: 17975144
[TBL] [Abstract][Full Text] [Related]
56. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
Sheffield BS; Kos Z; Asleh-Aburaya K; Wang XQ; Leung S; Gao D; Won J; Chow C; Rachamadugu R; Stijleman I; Wolber R; Gilks CB; Myles N; Thomson T; Hayes MM; Bernard PS; Nielsen TO; Chia SK
Breast Cancer Res Treat; 2016 Feb; 155(3):483-90. PubMed ID: 26846986
[TBL] [Abstract][Full Text] [Related]
57. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.
Roodi N; Bailey LR; Kao WY; Verrier CS; Yee CJ; Dupont WD; Parl FF
J Natl Cancer Inst; 1995 Mar; 87(6):446-51. PubMed ID: 7861463
[TBL] [Abstract][Full Text] [Related]
58. Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells.
Lanceta L; O'Neill C; Lypova N; Li X; Rouchka E; Waigel S; Gomez-Gutierrez JG; Chesney J; Imbert-Fernandez Y
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344635
[TBL] [Abstract][Full Text] [Related]
59. PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer.
Gao S; Ge A; Xu S; You Z; Ning S; Zhao Y; Pang D
J Exp Clin Cancer Res; 2017 Dec; 36(1):179. PubMed ID: 29216929
[TBL] [Abstract][Full Text] [Related]
60. Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression.
Stricker TP; Brown CD; Bandlamudi C; McNerney M; Kittler R; Montoya V; Peterson A; Grossman R; White KP
PLoS Genet; 2017 Mar; 13(3):e1006589. PubMed ID: 28263985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
